The drug industry’s about to plunge off a patent cliff, as blockbuster after blockbuster faces generic competition. But some companies are facing a steeper cliff than others.
That means that when the dust settles a few years from now, the rankings of the world’s top pharma companies will look pretty different than they do now. Pfizer [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment